Mary Bird Perkins Cancer Center in Covington announced its investment in new technology that can help doctors better understand, track, and treat/CT cancer patients. With GE Healthcare’s Discovery™ IQ PET/CT system, Mary Bird Perkins Cancer Center in Covington clinicians can pinpoint the smallest tumors and lesions due to the high sensitivity of the PET technology.
The aim of this product is to continuously improve diagnostic confidence for referring physicians and patients. The Discovery IQ also allows for fast and efficient scanning, which enables both half the PET dose and half the scan time. Speedy scans are helpful for elderly or sick patients that cannot hold still for a long time.
“Mary Bird Perkins has long prided itself on being on the leading-edge of cancer care, and GE Healthcare’s Discovery IQ PET/CT system will allow for the Cancer Center to continue leading the way with advanced early disease detection capabilities as well as tools to ensure patients’ optimal response to treatments,” said R. Scott Bermudez, MD, radiation oncologist, Mary Bird Perkins Cancer Center in Covington. “Our investment in this equipment will help us better examine, monitor, and provide enhanced care for our patients.”
The Discovery IQ system is primarily used to scan cancer patients and uses intelligent quantitation (IQ) to quantify changes in tumors and diseases. Quantitation can help clinicians detect cancer early and understand whether patients are responding to their current treatments. With those insights, clinicians can optimize treatment paths and tailor the appropriate therapy regimens according to patients’ unique needs.